Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

A1. Novel Agents

Poster Session: Novel Agents

(P-1073) Developing Vaccines and Antibodies Targeting Conserved Peptidoglycan, Lipoteichoic Acid, and Lipopolysaccharide Epitopes to Combat Antimicrobial Resistance

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT
Location: Halls JK

    Presenting Author(s)

  • Clara J. Sei, MPH (she/her/hers)

    Vice President, Vaccine and Antibody Development
    Longhorn Vaccines & Diagnostics, LLC
    Gaithersburg, Maryland, United States

    • Co-Author(s)

  • NR

    Nimisha Rikhi, PhD

    Senior Research Scientist
    Longhorn Vaccines & Diagnostics, LLC
    Gaithersburg, Maryland, United States

  • KK

    Kellie Kroscher, PhD

    Longhorn Vaccines & Diagnostics, LLC
    Gaithersburg, Maryland, United States

  • RS

    Richard F Schuman, PhD

    Antibody and Immunoassay Consultants
    Rockville, Maryland, United States

  • KM

    Kevin Muema, BS

    Research Associate
    Longhorn Vaccines & Diagnostics, LLC
    Gaithersburg, Maryland, United States

  • AA

    Aba Assiaw-Dufu, BS

    Longhorn Vaccines & Diagnostics, LLC
    Gaithersburg, Maryland, United States

  • GF

    Gerald W. Fischer, MD

    Chairman and Chief Executive Officer
    Longhorn Vaccines & Diagnostics, LLC
    Bethesda, Maryland, United States